TAYLOR MAHTOOK: Open Payments
NPI 1932658002 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 19 payments from 7 companies in 2025. Trend: 2023 $220 · 2024 $529 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $130 |
| Noven Therapeutics, LLC | 4 | $80 |
| Currax Pharmaceuticals LLC | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| ABBVIE INC. | 1 | $29 |
| MILLICENT US INC | 1 | $24 |
| Lilly USA, LLC | 1 | $15 |
Products named: Wegovy, Xelstrym, CAPLYTA, CONTRAVE, VRAYLAR, FEMLYV, MOUNJARO, ONZETRA XSAIL.
Industry payments across LA — which companies pay providers there.
